FI934625L - Sulfonamidderivat av bentsenfusionerade hydroxisubstituerade cykloalkyl- och heterocykliska ringfoereningar - Google Patents

Sulfonamidderivat av bentsenfusionerade hydroxisubstituerade cykloalkyl- och heterocykliska ringfoereningar Download PDF

Info

Publication number
FI934625L
FI934625L FI934625A FI934625A FI934625L FI 934625 L FI934625 L FI 934625L FI 934625 A FI934625 A FI 934625A FI 934625 A FI934625 A FI 934625A FI 934625 L FI934625 L FI 934625L
Authority
FI
Finland
Prior art keywords
sulfonamidderivat
ringfoereningar
hydroxisubstituerade
heterocykliska
benzenfusionerade
Prior art date
Application number
FI934625A
Other languages
English (en)
Finnish (fi)
Other versions
FI934625A0 (fi
FI934625A7 (fi
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI934625A0 publication Critical patent/FI934625A0/fi
Publication of FI934625A7 publication Critical patent/FI934625A7/fi
Publication of FI934625L publication Critical patent/FI934625L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/09Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Quinoline Compounds (AREA)
FI934625A 1992-10-21 1993-10-20 Sulfonamidderivat av bentsenfusionerade hydroxisubstituerade cykloalkyl- och heterocykliska ringfoereningar FI934625L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96433792A 1992-10-21 1992-10-21

Publications (3)

Publication Number Publication Date
FI934625A0 FI934625A0 (fi) 1993-10-20
FI934625A7 FI934625A7 (fi) 1994-04-22
FI934625L true FI934625L (fi) 1994-04-22

Family

ID=25508435

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934625A FI934625L (fi) 1992-10-21 1993-10-20 Sulfonamidderivat av bentsenfusionerade hydroxisubstituerade cykloalkyl- och heterocykliska ringfoereningar

Country Status (23)

Country Link
US (1) US5641789A (OSRAM)
EP (1) EP0665842A1 (OSRAM)
JP (1) JPH07508534A (OSRAM)
KR (1) KR950704309A (OSRAM)
CN (1) CN1090282A (OSRAM)
AP (1) AP9300578A0 (OSRAM)
AU (1) AU5536794A (OSRAM)
BR (1) BR9307277A (OSRAM)
CA (1) CA2146261A1 (OSRAM)
CZ (1) CZ100095A3 (OSRAM)
FI (1) FI934625L (OSRAM)
HR (1) HRP931297A2 (OSRAM)
HU (1) HUT68323A (OSRAM)
IL (1) IL107294A0 (OSRAM)
MA (1) MA23009A1 (OSRAM)
MX (1) MX9306528A (OSRAM)
NO (1) NO303224B1 (OSRAM)
PL (1) PL308474A1 (OSRAM)
RU (1) RU95109929A (OSRAM)
SI (1) SI9300554A (OSRAM)
TW (1) TW265335B (OSRAM)
WO (1) WO1994008996A1 (OSRAM)
ZA (1) ZA937782B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5539128A (en) * 1994-11-30 1996-07-23 Pfizer Inc. Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy chroman-3-ylmethyl]-4-methoxyaniline
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
ES2206738T3 (es) * 1996-09-16 2004-05-16 Pfizer Inc. Procedimientos e intermediarios para la preparacion de derivados sustituidos de cromanol.
ZA981080B (en) 1997-02-11 1998-08-12 Warner Lambert Co Bicyclic inhibitors of protein farnesyl transferase
GB9800039D0 (en) * 1998-01-02 1998-03-04 Univ Cardiff Benzyl and benzylidene tetralins and derivatives
RU2182004C1 (ru) * 2001-02-22 2002-05-10 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Лекарственный препарат для парентерального применения
JP4358515B2 (ja) * 2001-04-10 2009-11-04 タカラバイオ株式会社 治療剤
US7507531B2 (en) * 2002-10-17 2009-03-24 Decode Genetics Chf. Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
AU2003301305A1 (en) * 2002-10-17 2004-05-04 Decode Genetics Ehf. Susceptibility gene for myocardial infarction; methods of treatment
US7851486B2 (en) * 2002-10-17 2010-12-14 Decode Genetics Ehf. Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
EP1670445A2 (en) * 2003-09-17 2006-06-21 Decode Genetics EHF. Methods of preventing or treating recurrence of myocardial infarction
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
US20060210514A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin protection and moisturizing compositions and method of making the same
CN119912349B (zh) * 2023-10-31 2025-11-21 中国石油天然气股份有限公司 一种可降解凝胶用交联剂、制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
WO1990015801A1 (en) * 1989-06-22 1990-12-27 Pfizer Inc. Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases

Also Published As

Publication number Publication date
BR9307277A (pt) 1999-05-11
HU9302969D0 (en) 1993-12-28
MX9306528A (es) 1994-06-30
PL308474A1 (en) 1995-08-07
NO951506L (no) 1995-04-20
FI934625A0 (fi) 1993-10-20
IL107294A0 (en) 1994-01-25
KR950704309A (ko) 1995-11-17
AU5536794A (en) 1994-05-09
NO951506D0 (no) 1995-04-20
CN1090282A (zh) 1994-08-03
HRP931297A2 (en) 1996-08-31
EP0665842A1 (en) 1995-08-09
CZ100095A3 (en) 1995-11-15
MA23009A1 (fr) 1994-07-01
FI934625A7 (fi) 1994-04-22
WO1994008996A1 (en) 1994-04-28
RU95109929A (ru) 1997-03-20
CA2146261A1 (en) 1994-04-28
US5641789A (en) 1997-06-24
ZA937782B (en) 1995-04-20
TW265335B (OSRAM) 1995-12-11
AP9300578A0 (en) 1995-04-07
NO303224B1 (no) 1998-06-15
JPH07508534A (ja) 1995-09-21
SI9300554A (en) 1995-04-30
HUT68323A (en) 1995-06-28

Similar Documents

Publication Publication Date Title
FI934648A7 (fi) Foerfarande foer foergasning av avfallsaemnen innehaollande braennbara bestaondsdelar
FI924590A0 (fi) Foerfarande foer framstaellning av laekemedelskorn
FI932012L (fi) Foerfarande foer framstaellning av arylpiperazinyl-heterocykliska foereningar
FI933438A0 (fi) Anordning foer foerbindning av tvao ledningar
FI930636L (fi) Foerfarande foer framstaellning av en flerstegspolymer
FI931603A0 (fi) Foerfarande foer framstaellning av bifenylderivat
FI933902L (fi) Substituerade cyklohexanderivat foer behandling av sjukdomar
FI933066A0 (fi) Foerfarande foer avsvaertning av returpappersmassa
FI935103L (fi) Foerfarande foer faergning av kontaktlinser
FI932250L (fi) Foerfarande foer kontrollering av utfaellning av organiska foeroreningar ipappersmassa- och papperstillverkningsfoerfarande
FI931121L (fi) Bockningspress foer framstaellning av boejda glasrutor
FI934625L (fi) Sulfonamidderivat av bentsenfusionerade hydroxisubstituerade cykloalkyl- och heterocykliska ringfoereningar
FI934905A7 (fi) Anordning foer kapning av spirallindat metallroer
FI932848L (fi) Foerfarande foer blekning av pappersmassa
FI932726A0 (fi) Foerfarande foer framstaellning av nickelhydroxid
FI934570A0 (fi) Stabileringsapparatur foer utvidgning av en kompressors kurvskara
FI930412L (fi) Foerfarande foer delignifiering av raocellulosa
FI932375L (fi) Anvaendning av amorfisk silikoaluminat foer avlaegsning av kalciumutfaellningar
FI532U1 (fi) Vaetskeavskiljningsventil foer sprutroeret av en pappers- eller kartongmaskin
FI930395L (fi) Foerfarande foer framstaellning av bakverk
FI930384L (fi) Foerfarande foer kontinuerlig framstaellning av vinylaromatkopolymerer
FI920011L (fi) Av roerformade delar bildat vaeggelement
FI127U1 (fi) Anordning foer dosering av traevirke
FI240U1 (fi) Skyddsrum av betongelement
FI311U1 (fi) Kaerl foer mellanlagring av sandningsgrus

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed